Evidence map›Paper›PMID 40626159›Full record

ArticleFrontiers in public health2025

Impact of the COVID-19 pandemic on the consumption of antibiotics and the emergence of AMR: case study in a general hospital.

Urška Rozman, Konrad Kranjec, Aleksander Šeruga, Urška Kramar, Dominika Vrbnjak, Miha Lavrič, Sonja Šostar Turk

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Temporal Trends and Mortality of Vancomycin-ResistantPathogens (Basel, Switzerland) · 2026
    Observational
  3. Article
  4. Article
  5. Multicenter Surveillance ofInfection and drug resistance · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Urška RozmanFaculty of Health Sciences, University of Maribor, Maribor, Slovenia.
Konrad KranjecFaculty of Health Sciences, University of Maribor, Maribor, Slovenia.
Aleksander ŠerugaGeneral Hospital Ptuj, Ptuj, Slovenia.
Urška KramarNational Laboratory of Health, Environment and Food, Maribor, Slovenia.
Dominika VrbnjakFaculty of Health Sciences, University of Maribor, Maribor, Slovenia.
Miha LavričFaculty of Health Sciences, University of Maribor, Maribor, Slovenia.
Sonja Šostar TurkFaculty of Health Sciences, University of Maribor, Maribor, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The COVID-19 pandemic changed the use of antibiotics and had an impact on the development of antimicrobial resistance. The study aimed to examine the consumption of antibiotics and the occurrence of AMR infection and colonization in the selected general hospital. Methods: Data on antibiotic consumption and data on AMR infections and colonization were monitored in the period before the COVID-19 pandemic (2018, 2019) and during the COVID-19 pandemic (2020, 2021). Descriptive statistics, the Mann-Whitney U test, and the Pearson or Spearman correlation test were used. Results: The overall prescription of antibiotics stayed approximately the same, however, some important differences can be observed when analyzing specific groups of antibiotics (vancomycin, linezolid, piperacillin/tazobactam, meropenem, colistin). We did not observe the difference in the occurrence of AMR infections and colonizations before and during the pandemic. However, we did observe an alarming increase in CRaB, ESBL and VRE and highlighted the increase in all AMR groups between the first and second year of the pandemic. Conclusion: The connection between antibiotic consumption and the occurrence of AMR infections and colonization was confirmed.

Indexed as

Anti-Bacterial AgentsCOVID-19Drug Resistance, BacterialHospitals, GeneralHumansPandemicsSARS-CoV-2Anti-Bacterial AgentsAMRantibioticsCOVID-19general hospitalSlovenia

Identifiers

PMID40626159
PMCPMC12230027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.